Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Pfizer 15.034, Amgen 8.618.
Pfizer vs Amgen Net Worth and Market Cap
Pfizer (PFE) and Amgen (AMGN) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $8.6B for Amgen. Pfizer leads on revenue.
Pfizer's gross margin is 72.8% versus 68.2% for Amgen. Pfizer's net margin is -1.6% versus 21.1% for Amgen.
Key differences
- Revenue growth on the same quarter a year earlier: Amgen +5.8% (Q1 2026), Pfizer +2.6% (Q2 2026).
- Pfizer's KPIs on Sterling include Abrysvo Revenues by Region (Quarterly) and Comirnaty Revenues by Region (Quarterly).
- Amgen's KPIs on Sterling include AMG 513 Obesity Discontinuation and Cash and Cash Equivalents.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Amgen.| Metric | Pfizer | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $8.62B |
| Cost of Revenue | $4.09B | $2.74B |
| Gross Profit | $10.94B | $5.87B |
| Operating Income | $4.71B | $2.67B |
| Net Income | $-246.00M | $1.82B |
| R&D Expense | $2.81B | $1.72B |
| Earnings Per Share | -$0.04 | $3.34 |
| Gross Margin | 72.8% | 68.2% |
| Operating Margin | 31.3% | 30.9% |
| Net Profit Margin | -1.6% | 21.1% |
| Free Cash Flow | $302.00M | $1.48B |
| Cumulative Free Cash Flow | $356.70B | $165.69B |
| Operating Cash Flow | $835.00M | $2.19B |
| Cash & Equivalents | $976.00M | $12.04B |